Carpindolol
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 599099

CAS#: 39731-05-0

Description: Carpindolol is a beta-adrenergic blocking drug.


Chemical Structure

img
Carpindolol
CAS# 39731-05-0

Theoretical Analysis

MedKoo Cat#: 599099
Name: Carpindolol
CAS#: 39731-05-0
Chemical Formula: C19H28N2O4
Exact Mass: 348.20
Molecular Weight: 348.440
Elemental Analysis: C, 65.49; H, 8.10; N, 8.04; O, 18.37

Price and Availability

Size Price Availability Quantity
10mg USD 360 2 Weeks
50mg USD 1190 2 Weeks
Bulk inquiry

Synonym: Carpindolol; LM 21009; LM-21009; LM21009; SDZ 21009, SDZ21009, SDZ-21009

IUPAC/Chemical Name: isopropyl 4-(3-(tert-butylamino)-2-hydroxypropoxy)-1H-indole-2-carboxylate

InChi Key: SJYFDORQYYEJLB-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H28N2O4/c1-12(2)25-18(23)16-9-14-15(21-16)7-6-8-17(14)24-11-13(22)10-20-19(3,4)5/h6-9,12-13,20-22H,10-11H2,1-5H3

SMILES Code: O=C(C(N1)=CC2=C1C=CC=C2OCC(O)CNC(C)(C)C)OC(C)C

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 348.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Hoyer D, Schoeffter P, Waeber C, Palacios JM. Serotonin 5-HT1D receptors. Ann N Y Acad Sci. 1990;600:168-81; discussion 181-2. doi: 10.1111/j.1749-6632.1990.tb16880.x. PMID: 2252308.


2: Hedo G, Lopez-Garcia JA. 5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro. Br J Pharmacol. 2002 Feb;135(4):935-42. doi: 10.1038/sj.bjp.0704526. PMID: 11861321; PMCID: PMC1573193.


3: Frances H, Monier C, Debray M. Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptors. Pharmacol Biochem Behav. 1994 Aug;48(4):965-9. doi: 10.1016/0091-3057(94)90206-2. PMID: 7972302.


4: Chojnacka-Wójcik E, Kłodzińska A. Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats. J Neural Transm Gen Sect. 1992;87(2):87-96. doi: 10.1007/BF01245010. PMID: 1348421.


5: Chojnacka-Wójcik E. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Pol J Pharmacol Pharm. 1992 Mar-Apr;44(2):135-46. PMID: 1357637.


6: Schlicker E, Fink K, Göthert M, Hoyer D, Molderings G, Roschke I, Schoeffter P. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):45-51. doi: 10.1007/BF00169206. PMID: 2797214.


7: Molderings GJ, Werner K, Likungu J, Göthert M. Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype. Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):371-7. doi: 10.1007/BF00169451. PMID: 2255330.


8: Waeber C, Palacios JM. Non 5-HT1A/5-HT1C [3H]5-HT binding sites in the hamster, opossum, and rabbit brain show similar regional distribution but different sensitivity to beta-adrenoceptor antagonists. Synapse. 1992 Dec;12(4):261-70. doi: 10.1002/syn.890120403. PMID: 1361246.


9: Mitsikostas DD, Sanchez del Rio M, Moskowitz MA, Waeber C. Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. Eur J Pharmacol. 1999 Mar 26;369(3):271-7. doi: 10.1016/s0014-2999(99)00067-9. PMID: 10225363.


10: Chojnacka-Wójcik E, Przegaliński E. Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats. Neuropharmacology. 1991 Jul;30(7):703-9. doi: 10.1016/0028-3908(91)90177-d. PMID: 1681448.


11: Ishizuka J, Beauchamp RD, Townsend CM Jr, Greeley GH Jr, Thompson JC. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol. 1992 Jan;150(1):1-7. doi: 10.1002/jcp.1041500102. PMID: 1309821.


12: Cattaneo MG, Palazzi E, Bondiolotti G, Vicentini LM. 5-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma. Eur J Pharmacol. 1994 Aug 16;268(3):425-30. doi: 10.1016/0922-4106(94)90068-x. PMID: 7805767.


13: Berthold H, Fozard JR, Engel G. 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol. 1989 Mar 14;162(1):19-27. doi: 10.1016/0014-2999(89)90599-2. PMID: 2566495.


14: Schoeffter P, Hoyer D. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta- adrenoceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol. 1989 Sep;340(3):285-92. doi: 10.1007/BF00168512. PMID: 2572975.


15: Waeber C, Dietl MM, Hoyer D, Palacios JM. 5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):486-94. doi: 10.1007/BF00260602. PMID: 2533325.


16: Waeber C, Schoeffter P, Palacios JM, Hoyer D. 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):479-85. doi: 10.1007/BF00260601. PMID: 2533324.


17: Waeber C, Palacios JM. 5-HT1 receptor binding sites in the guinea pig superior colliculus are predominantly of the 5-HT1D class and are presynaptically located on primary retinal afferents. Brain Res. 1990 Oct 1;528(2):207-11. doi: 10.1016/0006-8993(90)91659-5. PMID: 2271922.